Commentary · 21 Feb 2026
Conference abstractPublished 18 Oct 2017
Digital-NGS identifies mutations in pancreatic juice in patients with pancreatic cancer
Johns Hopkins University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Genetic analysis of secretin-stimulated pancreatic juice which contains DNA shed from cell linings of the pancreatic ducts may form a test parameter to detect pancreatic ductal neoplasia. Next-generation sequencing (NGS) is widely evaluated as a test to detect mutations in many cancers. However, sequencing errors generated by standard NGS assays limit the ability to identify the mutations at concentrations. Methods: We employed digital-next-generation sequencing (âÂ?Â?digital-NGSâÂ?) to detect low-abundance mutations in pancreatic juice samples of 115 subjects with either pancreatic ductal adenocarcinoma, intraductal papillary mucinous neoplasms, a familial predisposition to pancreatic cancer undergoing pancreatic screening, or controls without evidence of neoplasia. Results: Digital-NGS could detect all 28 mutations present at concentration ranging from >0.1 to 1% relative to wild-type DNA. Cases with PDAC and IPMN were more likely and significant to have mutant DNA detected in pancreatic juice than controls. TP53 and/ or SMAD4 mutations were commonly detected in juice samples from patients with PDAC and were not detected in controls; mutant TP53/SMAD4 concentrations could distinguish PDAC from IPMN cases and controls. Two of the four patients who developed pancreatic cancer while under surveillance had mutations (TP53 and SMAD4) from their cancer, detected in juice samples collected over one year prior to their pancreatic cancer diagnosis when no suspicious pancreatic lesions were detected by imaging. Conclusions: The detection in pancreatic juice of mutations are important for the progression of low-grade dysplasia to high-grade dysplasia and invasive pancreatic cancer. Therefore, this may improve the management of patients undergoing pancreatic screening and surveillance.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Jun Yu”
